CARDIOMETRICS' FLOWIRE/FLOMAP SALES SURGE 70% TO $8.5 MIL.
This article was originally published in The Gray Sheet
Executive Summary
CARDIOMETRICS' FLOWIRE/FLOMAP SALES SURGE 70% TO $8.5 MIL. in 1993, company President and CEO Menahem Nassi told investors Jan. 10 at the Hambrecht & Quist life sciences conference in San Francisco. The two products provided all the privately held Mountain View, California-based firm's revenues during the year; 60% of the sales were from overseas markets. FloWire and FloMap generated $1 mil. in sales in the half year they were available in 1991.